Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-038442
Filing Date
2009-02-26
Accepted
2009-02-26 11:26:09
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ADOLOR CORPORATION d10k.htm 10-K 805394
2 AMENDMENT TO LETTER AGREEMENT - MICHAEL R. DOUGHERTY dex1011.htm EX-10.11 8477
3 AMENDMENT TO LETTER AGREEMENT - ELISEO ORESTES SALINAS, MD, MSC dex1013.htm EX-10.13 6905
4 SUMMARY OF ORAL AGREEMENT dex1021.htm EX-10.21 8326
5 CONSENT OF KPMG LLP dex231.htm EX-23.1 2183
6 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 8835
7 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 8853
8 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 2544
9 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2583
10 GRAPHIC g49840g85b12.jpg GRAPHIC 81248
  Complete submission text file 0001193125-09-038442.txt   967500
Mailing Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
Business Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
ADOLOR CORP (Filer) CIK: 0001076167 (see all company filings)

EIN.: 311429198 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30039 | Film No.: 09636253
SIC: 2834 Pharmaceutical Preparations